Background Marginal zone lymphoma (MZL) is a non-Hodgkin lymphoma that occurs as
extra nodal, nodal, or splenic. While MZL is generally considered an indolent disease, a …

Purpose Given the paucity of data on higher-grade transformation (HGT) to aggressive
lymphoma in patients with marginal zone lymphoma (MZL), we report on a large cohort of …

BACKGROUND: A retrospective review and analysis of 275 patients with marginal zone
lymphoma (MZL) was performed to determine prognostic factors. An effort was also made to …

Marginal zone lymphomas (MZLs) are a diverse group of indolent non-Hodgkin lymphoma
(NHL) sharing a similar immunophenotype but exhibiting unique biology, clinical features …

BACKGROUND. Prognostic factors and outcomes in patients with marginal zone lymphoma
(MZL) have been studied in small cohort studies, which may not reflect the population at …

Marginal zone lymphoma (MZL) is an indolent B-cell malignancy with heterogeneous
anatomical and clinical presentation. While MZLs are generally associated with long …

Histological transformation into an aggressive B-cell lymphoma indicates a poor survival
outcome for patients with indolent marginal zone lymphoma (MZL), which has been less …

BACKGROUND: In marginal zone lymphoma (MZL), clinical and follow‐up data on large
cohorts of patients are difficult to obtain. The objective of this single‐center, retrospective …

Extranodal marginal zone lymphoma (EMZL) is a B‐cell lymphoma arising from mucosa‐
associated lymphoid tissue (MALT). The disease characteristics, clinical course and …

Background Localized early-stage extra-nodal marginal zone lymphoma (MZL) presents
with heterogeneous organ involvement and is treated with various modalities, including …